Precigen, Inc. Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
PGEN Company Description
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
PGEN Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view PGEN Smart Score
Score Breakdown
PGEN Company Description
Show More
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of PGEN by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by PGEN's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of PGEN in WallStreetBets Daily Discussion
PGEN News
Recent insights relating to PGEN
CNBC Recommendations
Recent picks made for PGEN stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in PGEN
Corporate Flights
Flights by private jets registered to PGEN
Our Analysis